Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Mohsen Haidary
The effective delivery of therapeutic agents to their target sites within the human body is a complex endeavor that relies on a myriad of intricate processes. Central to this challenge are the cellular gateways, specialized membrane transport proteins that regulate the movement of molecules across cell membranes. These gatekeepers, known as drug transporters, play a pivotal role in modulating the absorption, distribution, and excretion of drugs and other molecules. As such, understanding the functioning and regulation of drug transporters is paramount for optimizing therapeutic delivery strategies and enhancing drug efficacy. As the field continues to evolve, researchers are uncovering novel strategies to exploit drug transporters for targeted drug delivery and enhanced therapeutic outcomes. We discuss current approaches that leverage transporter-mediated drug delivery systems, including prodrugs, nanoparticles, and carrier-mediated transport.